134 related articles for article (PubMed ID: 3167207)
1. Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.
Shimazaki C; Wisniewski D; Scheinberg DA; Atzpodien J; Strife A; Gulati S; Fried J; Wisniewolski R; Wang CY; Clarkson BD
Blood; 1988 Oct; 72(4):1248-54. PubMed ID: 3167207
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
[TBL] [Abstract][Full Text] [Related]
3. Selective depletion of human myeloma clonogenic stem cells from bone marrow cell preparations by a plasma-cell reactive antibody and complement.
Stone MJ; Tong AW; Fay JW; Lee JC
Cancer Detect Prev; 1988; 12(1-6):621-35. PubMed ID: 3180147
[TBL] [Abstract][Full Text] [Related]
4. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads.
Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C
Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147
[TBL] [Abstract][Full Text] [Related]
5. Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads.
Reynolds CP; Seeger RC; Vo DD; Black AT; Wells J; Ugelstad J
Cancer Res; 1986 Nov; 46(11):5882-6. PubMed ID: 3756928
[TBL] [Abstract][Full Text] [Related]
6. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
Elias AD; Pap SA; Bernal SD
Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
[TBL] [Abstract][Full Text] [Related]
7. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
[TBL] [Abstract][Full Text] [Related]
8. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.
Kvalheim G; Fodstad O; Pihl A; Nustad K; Pharo A; Ugelstad J; Funderud S
Cancer Res; 1987 Feb; 47(3):846-51. PubMed ID: 3492268
[TBL] [Abstract][Full Text] [Related]
9. Elimination of drug-resistant myeloma tumor cell lines by monoclonal anti-P-glycoprotein antibody and rabbit complement.
Kulkarni SS; Wang ZM; Spitzer G; Taha M; Hamada H; Tsuruo T; Dicke KA
Blood; 1989 Nov; 74(6):2244-51. PubMed ID: 2572283
[TBL] [Abstract][Full Text] [Related]
10. Elimination of clonogenic stem cells from human multiple myeloma cell lines by a plasma cell-reactive monoclonal antibody and complement.
Tong AW; Lee JC; Fay JW; Stone MJ
Blood; 1987 Nov; 70(5):1482-9. PubMed ID: 3663943
[TBL] [Abstract][Full Text] [Related]
11. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use.
Kvalheim G; Sørensen O; Fodstad O; Funderud S; Kiesel S; Dörken B; Nustad K; Jakobsen E; Ugelstad J; Pihl A
Bone Marrow Transplant; 1988 Jan; 3(1):31-41. PubMed ID: 3048468
[TBL] [Abstract][Full Text] [Related]
12. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies.
De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A
Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo treatment of myeloma cells by 4-HC, VP-16, LAK cells and antibodies.
Gulati SC; Shimazaki C; Lemoli RM; Atzpodien J; Clarkson BD
Eur J Haematol Suppl; 1989; 51():164-72. PubMed ID: 2627987
[TBL] [Abstract][Full Text] [Related]
14. Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres.
O'Briant KC; Shpall EJ; Houston LL; Peters WP; Bast RC
Cancer; 1991 Sep; 68(6):1272-8. PubMed ID: 1873781
[TBL] [Abstract][Full Text] [Related]
15. Isolation of hemopoietic precursor cells from human marrow by negative selection using monoclonal antibodies and immunomagnetic beads.
Cottler-Fox M; Bazar LS; Deeg HJ
Prog Clin Biol Res; 1990; 333():277-84. PubMed ID: 2308986
[TBL] [Abstract][Full Text] [Related]
16. Model experiments for immunomagnetic elimination of leukemic cells from human bone marrow. Presentation of a novel magnetic separation system.
Gruhn B; Häfer R; Müller A; Andrä W; Danan H; Zintl F
Immunobiology; 1991 Nov; 183(5):374-85. PubMed ID: 1786986
[TBL] [Abstract][Full Text] [Related]
17. An effective immunomagnetic method for bone marrow purging in T cell malignancies.
Wang MY; Kvalheim G; Kvaløy S; Beiske K; Jakobsen E; Wijdenes J; Pihl A; Fodstad O
Bone Marrow Transplant; 1992 May; 9(5):319-23. PubMed ID: 1617315
[TBL] [Abstract][Full Text] [Related]
18. Effective removal of SCLC cells from human bone marrow. Use of four monoclonal antibodies and immunomagnetic beads.
Myklebust AT; Pharo A; Fodstad O
Br J Cancer; 1993 Jun; 67(6):1331-6. PubMed ID: 8390285
[TBL] [Abstract][Full Text] [Related]
19. Autologous bone marrow transplantation for B cell malignancies after in vitro purging with floating immunobeads.
Stoppa AM; Hirn J; Blaise D; Delaage M; Novakovitch G; Viens P; Capiello MA; Mannoni P; Mawas C; Maraninchi D
Bone Marrow Transplant; 1990 Nov; 6(5):301-7. PubMed ID: 2291992
[TBL] [Abstract][Full Text] [Related]
20. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.
LaCasse EC; Bray MR; Patterson B; Lim WM; Perampalam S; Radvanyi LG; Keating A; Stewart AK; Buckstein R; Sandhu JS; Miller N; Banerjee D; Singh D; Belch AR; Pilarski LM; Gariépy J
Blood; 1999 Oct; 94(8):2901-10. PubMed ID: 10515895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]